 |
| Biomutant |
- Release: May 25, 2021
- Mode: Single-player
- Genre: Action / Role-Playing Game (RPG)
- Developer: Experiment 101
- Publisher: THQ Nordic GmbH
1. Game overview
Will you be the savior of the new world, or will you lead it to a fate more disastrous than that?
Biomutant is a post-apocalyptic open world action RPG that has unique martial arts and modern combat system, allowing you to combine hand-to-hand combat, shooting and the thrill of mutant ability together.
A new world pandemic strikes and blood is spilled everywhere. The tribes find themselves scattered, needing someone strong to unite them or make them collapse forever.
Explore a world in chaos and determine its destiny - your actions and choices will finally put an end to your survival story.
2. Game features
 |
| Biomutant game features |
Recreate your genetic makeup
Create your own unique character by choosing from characteristics and classes to suit your playstyle. Continue to unlock new abilities such as Turtleform and Mucus Bubble during transformations in different regions of this world.
Excel at fighting
Combine hand-to-hand combat, shooting and abilities gained from transformations while battling a plethora of post-apocalyptic enemies. Comprehensive crafting system that lets you combine and build remnants of hand-to-hand combat weapons, as well as pistols, rifles, machine guns, and more.
Explore a vast and vibrant world
Go fast and explore a huge and vast open world environment above and below ground on foot, in a machine, in a jet sled, in an air balloon or unique air transportation.
System Requirements
- OS: Windows 7/8.1/10 (64 bit)
- Processor: AMD FX-8350 or Intel Core i5-4690K or newer running at 3.5 GHz or higher
- Memory: 8 GB RAM
- Graphics: 4 GB Direct3D 11 capable video card – GeForce GTX 960 or Radeon R9 380
- DirectX: Version 11
- Storage: 25 GB available space
- Sound Card: Integrated or dedicated DirectX 9 compatible soundcard
- Additional Notes: Keyboard, mouse and an internet connection for Steam.
 |
Size: 14.54 GB |
0 Comments